These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35210003)

  • 1. Novel Ventilation Strategies to Reduce Adverse Pulmonary Outcomes.
    Keszler M
    Clin Perinatol; 2022 Mar; 49(1):219-242. PubMed ID: 35210003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory management in the premature neonate.
    Dumpa V; Avulakunta I; Bhandari V
    Expert Rev Respir Med; 2023 Feb; 17(2):155-170. PubMed ID: 36803028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we balance early exogenous surfactant therapy and non-invasive respiratory support to optimise outcomes in extremely preterm infants? A nuanced review of the current literature.
    Glaser K; Bamat NA; Wright CJ
    Arch Dis Child Fetal Neonatal Ed; 2023 Nov; 108(6):554-560. PubMed ID: 36600473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal ventilatory strategies and surfactant to protect the preterm lungs.
    Ramanathan R
    Neonatology; 2008; 93(4):302-8. PubMed ID: 18525214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 7. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Ventilation and Exogenous Surfactant in Times of Ever Decreasing Gestational Age: How Do We Make the Most of These Tools?
    Wright CJ; Glaser K; Speer CP; Härtel C; Roehr CC
    J Pediatr; 2022 Aug; 247():138-146. PubMed ID: 35429507
    [No Abstract]   [Full Text] [Related]  

  • 12. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical Ventilation and Bronchopulmonary Dysplasia.
    Keszler M; Sant'Anna G
    Clin Perinatol; 2015 Dec; 42(4):781-96. PubMed ID: 26593078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome.
    Garland JS; Buck RK; Allred EN; Leviton A
    Arch Pediatr Adolesc Med; 1995 Jun; 149(6):617-22. PubMed ID: 7767415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Developments in Respiratory Support for Preterm Infants.
    Jain D; Bancalari E
    Am J Perinatol; 2019 Jul; 36(S 02):S13-S17. PubMed ID: 31238352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 18. "New" bronchopulmonary dysplasia and chronic lung disease.
    Voynow JA
    Paediatr Respir Rev; 2017 Sep; 24():17-18. PubMed ID: 28697967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Devi U; Pandita A
    Pediatr Pulmonol; 2021 Oct; 56(10):3126-3141. PubMed ID: 34379878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.